Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
Recruiting · NCT07095465 · Registry updated 2026-09-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis | Lewy Body Dementia Psychosis | Recruiting | Phase 3 | 2026-09-29 | NCT07095465 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| ACADIA Pharmaceuticals Inc. | 9 |
32 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.